Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ron Kalfus, Guy Malchi, Steve Miller

Premium

Rosetta Genomics announced the appointment of three new senior management team members.

Recently joining the firm as CFO is Ron Kalfus, who most recently served as CFO of cancer detection firm MabCure.

Also joining the company is Guy Malchi, who will serve as Rosetta's new executive vice president of corporate development. He previously was general manager and head of pharma at Champions Oncology.

Lastly, Rosetta has hired Steve Miller as its director of marketing and reimbursement. He previously served as the owner and operator of an independent reimbursement consultancy firm. Before that, he was worldwide product director at Veridex.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.